Showing results (761-770 of 892) with videos related to
Sort By:
Pageof 90
Nature Communications|August 3, 2023
Boreal conifers maintain carbon uptake with warming despite failure to track optimal temperaturesMirindi Eric Dusenge, Jeffrey M Warren, Peter B Reich, et al.Journal of Hospital Medicine|February 23, 2019
Care Transitions Program for High-Risk Frail Older Adults is Most Beneficial for Patients with Cognitive ImpairmentBjorg Thorsteinsdottir, Stephanie M Peterson, James M Naessens, et al.JCI Insight|December 5, 2023
Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexiaDavis A Englund, Alyssa M Jolliffe, Gabriel J Hanson, et al.Critical Care Medicine|February 10, 2021
Age-Dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-Associated Thrombosis in Critically Ill Children: A Post Hoc Analysis of a Bayesian Phase 2b Randomized Clinical TrialE Vincent S Faustino, Leslie J Raffini, Sheila J Hanson, et al.Journal of Primary Care & Community Health|April 3, 2026
Health Care Use and Outcomes Among Participants Enrolled in the Mayo Clinic Primary Care House Call Program: A Case-Control StudyPaul Y Takahashi, Bonnie C Sohn, Brandon P Verdoorn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancerGrace K Dy, Laura M Bruzek, Gary A Croghan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancerGrace K Dy, James P Thomas, George Wilding, et al.The Journal of Infectious Diseases|January 4, 2008
Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malariaA M Dondorp, C Ince, P Charunwatthana, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2008
Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90Thomas E Barta, James M Veal, John W Rice, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferationS L Woulfe, C P Bono, M L Zacheis, et al.Pageof 90